{
    "2021-02-13": [
        [
            {
                "time": "",
                "original_text": "新股解读|CXO行业迎新，昭衍新药携17亿在手订单赴港融资",
                "features": {
                    "keywords": [
                        "CXO行业",
                        "昭衍新药",
                        "17亿订单",
                        "赴港融资"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德：参股公司Adagene Inc.在纳斯达克上市",
                "features": {
                    "keywords": [
                        "药明康德",
                        "Adagene Inc.",
                        "纳斯达克上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}